MDVerse Inc. provides a software, analytics, and generative AI platform designed to support the advanced therapy medicinal products (ATMP) ecosystem. The company integrates drug creators, pharmaceutical companies, contract manufacturers, and clinical sites to streamline the supply chain, manufacturing, and delivery of precision cell and gene therapies.
Subscribe to see MDVerse Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
MDVerse Inc. is a biotechnology company headquartered in Fremont, United States. Its most recent funding round raised $375,000 in August 2022. Xcout tracks 4 named people at MDVerse Inc., including Dawn Daniel (MD, FAASM, Co-Founder, CEO).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $375,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of MDVerse Inc.'s closest competitors — see the full list of competitors and alternatives →
Concerto HealthAI was a healthcare technology company that used artificial intelligence and real-world data to support drug development and precision medicine. It primarily served biopharmaceutical companies, helping them generate clinical evidence and identify or stratify patients, particularly in oncology.
Avenue Biosciences provides a machine learning-powered protein engineering platform designed to optimize secretory pathways for therapeutic protein manufacturing. The company serves biotechnology and pharmaceutical developers by enhancing the yield, quality, and production of difficult-to-express proteins, biologics, and gene therapies.
Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
Trially Inc. operates an AI-native clinical trial recruitment platform that utilizes HIPAA-compliant LLM agents to match, engage, and enroll qualified participants.
Biorce is a biotechnology research company headquartered in Barcelona, Spain, with a team of around 180 employees. The company develops artificial intelligence platforms and operating systems designed to automate and streamline clinical trials with built-in review processes and human oversight.
Strategikon Pharma is a technology company that provides cloud-based software solutions for the pharmaceutical industry. Its platform specializes in optimizing clinical trial business operations, including clinical budgeting, vendor management, and outsourcing planning.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about MDVerse Inc.? Suggest a correction · Work at MDVerse Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.